Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis...

Area of Science:

• Cardiovascular Surgery
• Vascular Biology
• Interventional Cardiology

Background:

• Saphenous vein graft (SVG) intimal hyperplasia is a primary cause of graft atherosclerosis and occlusion post-coronary artery bypass grafting (CABG).
• Understanding factors associated with SVG intimal hyperplasia and occlusion is crucial for improving long-term graft patency.

Purpose of the Study:

• To investigate patient characteristics, anatomical factors, and medications associated with SVG intimal hyperplasia and occlusion one year after CABG.

Main Methods:

• A post hoc analysis of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial was conducted.
• 322 grafts were assessed by angiography and 90 by intravascular ultrasound at 1 year post-CABG.
• Correlates including patient characteristics, medications, target vessel characteristics, and SVG diameter were evaluated.

Main Results:

• At 1 year, the mean SVG intimal area was 4.3 ± 2.1 mm², and the occlusion rate was 6.2%.
• Independent correlates of hyperplasia included larger SVG diameter, hypertension, and grafting to the right coronary territory.
• Statin and beta-blocker use were associated with reduced intimal hyperplasia, while low target vessel quality correlated with SVG occlusion.

Conclusions:

• Hypertension, larger SVG diameter, and grafting to the right coronary artery are associated with increased SVG hyperplasia or occlusion.
• Beta-blockers and statins demonstrate a protective effect, correlating with less SVG disease.
• These findings enhance understanding of SVG remodeling and may inform strategies to prevent post-CABG SVG disease.